Compare DAKT & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAKT | INM |
|---|---|---|
| Founded | 1968 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.1M | 3.7M |
| IPO Year | 1994 | N/A |
| Metric | DAKT | INM |
|---|---|---|
| Price | $18.54 | $1.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $26.00 | N/A |
| AVG Volume (30 Days) | ★ 515.8K | 137.3K |
| Earning Date | 12-10-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $770,283,000.00 | $4,798,116.00 |
| Revenue This Year | $13.76 | N/A |
| Revenue Next Year | $7.35 | N/A |
| P/E Ratio | $126.96 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.24 | $1.13 |
| 52 Week High | $24.38 | $8.27 |
| Indicator | DAKT | INM |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 40.93 |
| Support Level | $18.16 | $1.18 |
| Resistance Level | $19.08 | $1.35 |
| Average True Range (ATR) | 0.87 | 0.10 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 23.92 | 17.19 |
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.